Home › NDC Lookup › Ingredients › Salicylic Acid › 51326-0712-60
Gly-Sal 10-2 Salicylic Acid 20 mg Cloth, 60-count — NDC 51326-0712-60 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Gly-Sal 10-2 Salicylic Acid 20 mg Cloth, 60-count — NDC 51326-712-60 (Billing 51326-0712-60)

by Topiderm, Inc. · 60 CLOTH in 1 JAR

This is a package of 60 cloths of Gly-Sal 10-2 Salicylic Acid 20 mg Cloth from Topiderm, Inc., marketed since May 2019 and currently FDA-listed. It is this product's only package size.

NDC 51326-0712-60
🏷️ FDA NDC (as labeled) 51326-712-60 billing pads the product segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 51326-712-60 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
51326 labeler · 712 product · 60 package
Package marketed since
May 28, 2019
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Barcode (UPC-A, from the NDC)
3 5132671260 4
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 51326-712-60
Product NDC 51326-712
11-digit billing NDC 51326071260
RxCUI 797892
UNII O414PZ4LPZ
Application # M006
SPL Set ID 4058327e-2764-4df0-9d5d-7cda72d9ca41
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2019-05-28
Route TOPICAL
Dosage form CLOTH
Substance SALICYLIC ACID
Quick answers
  • RxCUI (RxNorm): 797892
Why two NDCs? The FDA registers this code as 51326-712-60 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 51326-0712-60. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Salicylic acid and derivatives class.

Drug family (ATC) Salicylic acid and derivatives, Other antifungals for topical use, Antiinflammatory agents, non-steroids
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

📖 What it is MedlinePlus · NLM

Topical salicylic acid is used to help clear and prevent pimples and skin blemishes in people who have acne. Topical salicylic acid is also used to treat skin conditions that involve scaling or overgrowth of skin cells such as psoriasis (a skin disease in which red, scaly patches form on some areas of the body), ichthyoses (inborn conditions that cause skin dryness and scaling), dandruff, corns, calluses, and warts on the hands or feet. Topical salicylic acid should not be used to treat genital warts, warts on the face, warts with hair growing from them, warts in the nose or mouth, moles, or b...

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • It is used in a facial routine for acne-prone and oil-prone skin. The routine includes a cleanser, serum, toner and emulsion. Salicylic acid helps loosen and shed dead skin cells.
  • Use the cleanser morning and evening, and the serum in the morning after cleansing. Use the toner in the evening on dry skin, and the emulsion at night after cleansing. Avoid your...
  • Mild stinging, burning, itching, dryness and extra peeling can happen. If dryness or peeling bothers you, try using the serum or toner every other day. If it gets excessive, stop a...
  • It is best not to. Using another topical acne medication at the same time makes irritation and dryness more likely. If you get irritated, use only one at a time.
📖 Read our full Salicylic Acid Topical guide →

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
51326-0712-60 You're viewing this Main listing 60 CLOTH in 1 JAR 2019-05-28 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Stridex Maximum 2 g/100mL 10157-1006-01 Blistex 1 jar — — FDA listed —
Stridex XL Face and Body Pads 2 g/100mL 10157-2114-01 Blistex 1 jar — — FDA listed —
OXY ADVANCED CARE 3 in 1 RETEXTURIZING CLEANSING PADS 20 mg 10742-1000-01 The 90 swabs — — FDA listed —
Oxy Deep Pore Acne Cleansing Pads 20 mg 10742-1006-01 The 90 cloths — — FDA listed —
Oxy 3-IN-1 Acne Cleansing Pads 20 mg 10742-1008-01 The 90 cloths — — FDA listed —
Oxy 3-IN-1 Acne Cleansing Pads 20 mg 10742-1010-01 The 90 fors — — FDA listed —
Oxy Deep Pore Acne Cleansing Pads 20 mg 10742-1011-01 The 90 fors — — FDA listed —
OXY ADVANCED CARE MAXIMUM STRENGTH 3-in-1 ACNE PADS 20 mg 10742-1200-01 The 90 swabs — — FDA listed —
OXY Deep Pore Cleansing Pads 20 mg 10742-4204-01 The 90 swabs — — FDA listed —
OXY 3 in 1 Acne Pads 20 mg 10742-4359-01 The 90 swabs — — FDA listed —
Proactiv CLEAR ZONE BODY PADS 2 g/100mL 11410-0056-00 Alchemee, 75 applicators — — FDA listed —
ZO Skin Health Oil Control Pads Acne Treatment 20 mg/mL 42851-0085-30 ZO 30 patches — — FDA listed —
Thayers Since 1847 Natural Remedies Blemish Clearing Witch Hazel Aloe Vera Formula Pads 20 mg/mL 49967-0705-01 L'Oreal 60 applicators — — FDA listed —
Gly-Sal 5-2 Pads .02 g 51326-0038-60 Topiderm, 60 cloths — — FDA listed —
Gly-Sal 10-2 Pads .02 g 51326-0039-60 Topiderm, 60 cloths — — FDA listed —
Gly-Sal 10-2 20 mgthis 51326-0712-60 Topiderm, 60 cloths — — FDA listed —
Gly-Sal 2-2 Pads 20 mg 51326-0923-01 Topiderm, 60 cloths — — FDA listed —
Max Complexion Correction Pads 2 g/100mL 54031-0501-22 PETER 60 patches — — FDA listed —
Equate Beauty Quick Action Pads Salicylic Acid Acne Treatment 20 mg/mL 61805-0117-01 Bath 90 patches — — FDA listed —
DermaClear Pads 20 mg/g 62742-4076-02 Allure 1 jar — — FDA listed —
Universal Clarifying Pad 20 mg/g 62742-4276-02 Allure 1 jar — — FDA listed —
Clearasil Rapid Rescue Deep Treatment Pads .02 g 63824-0431-90 Reckitt 90 cloths — — FDA listed —
Noxzema ANTIBLEMISH .02 g/g 64942-1259-01 Conopco 0284 g — — FDA listed —
Rush Salicylc Acid Complexion Pads 2 g/100g 65113-1201-01 G.S. 1 jar — — FDA listed —
Anti-Aging Blemish Control Peel Pads 2.366 g/118.29g 65278-0318-01 June 118.29 g — — FDA listed —
Neutrogena Rapid Clear Treatment Pads 20 mg 69968-0719-06 Kenvue 60 cloths — — FDA listed —
Retexturizing Body Pads 2 g/100mm 70381-0126-02 Murad, 1 jar — — FDA listed —
Cleansing Wipes 2 g/100mL 71613-0001-01 Nextcell 25 applicators — — FDA listed —
FHF Change Peel Pads 2 g/100g 72788-0183-02 Summer 1 bottle — — FDA listed —
Acne Correction Pads 2 g/100mL 72957-0012-01 Private 1 jar — — FDA listed —
AHA/BHA Swipes 2 g/100mL 73318-7004-06 SKIN 1 jar — — FDA listed —
ESSENCE BY CATHERINE HINDS PURIFYING PADS with 2% Salicylic Acid 2 g/100mL 76446-0022-50 Anna 1 jar — — FDA listed —
anna lotan PURIFYING PADS with 2% Salicylic Acid 2 g/100mL 76446-0039-50 Anna 1 jar — — Discontinued —
Equate 2% Salicylic acid Acne treatment pad 2 g/100g 79903-0062-01 Walmart, 165 g — — FDA listed —
Maximum Sterngth Cleansing Pads Equate 2 g 79903-0207-01 Walmart 1 jar — — FDA listed —
Tingl Exfoliating Pads 2 g/100g 83286-0011-01 Drmtlgy, 60 patches — — FDA listed —
Crystal Clear Acne Treatment Pads 2 g/100mL 83316-0001-01 Skin 60 patches — — Discontinued —
First Aid Beauty Acne Clearing Pads 2 g/100mL 84126-0119-60 The 60 patches — — FDA listed —
Tula Skincare Breakout Breakthrough Acne Toner Pads 2 g/1001 84126-0152-30 The 1 jar — — FDA listed —
Acne Treatment Cotton Pads 2 g/100g 84356-0003-01 Guangzhou 100 g — — FDA listed —
Societe Clear Skin Pads 2 g/100g 87700-0147-02 Societe 1 jar — — FDA listed —
Dr. Zenovia Clear Complexion 20 mg 51326-0801-01 Topiderm, 1 bottle — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2019
On the market since
May 2019
📍
2026
Currently FDA-listed
7 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 1364PS73AF
    Acetone is a clear, volatile liquid solvent. In medications, it helps dissolve or extract active ingredients during manufacturing and may be used in certain liquid formulations or coating processes.
  • 130 mL UNII 7528N5H79B
    A liquid solvent derived from grain fermentation. In medicines, it dissolves active ingredients, helps preserve the product, and improves how the body absorbs the drug.
  • UNII 5138Q19F1X
    Ammonia is a colorless gas made from nitrogen and hydrogen. It's used in medicines as a pH buffer to maintain the correct acidity level and help keep the product stable.
  • UNII 7FLD91C86K
    Edetate disodium is a chemical compound that binds and removes certain metal ions. In medicines, it acts as a preservative and stabilizer by preventing metals like calcium from interfering with the product's shelf life and consistency.
  • 100 mg UNII 0WT12SX38S
    Glycolic acid is an alpha-hydroxy acid derived from sugar cane that helps dissolve and remove dead skin cells. In topical medicines, it works as an exfoliant and pH adjuster to improve skin penetration and product effectiveness.
  • UNII 8FP93ED6H2
    Witch hazel is a plant extract made from the leaves and twigs of the witch hazel shrub. In medicines, it works as a soothing and astringent ingredient that helps reduce inflammation and tighten skin.
  • UNII M629807ATL
    Imidazolidinyl urea is a synthetic preservative that prevents microbial growth in medicines. It's used in formulations to extend shelf life and maintain product safety during storage.
  • UNII 7T1F30V5YH
    A synthetic emulsifier derived from sorbitol and oleic acid. It helps mix oil and water-based ingredients together and keeps them from separating in liquid formulations.
  • UNII OJ245FE5EU
    Sodium benzoate is a salt derived from benzoic acid, a preservative. It's added to medicines to prevent growth of bacteria, fungi, and other microorganisms that could spoil the product.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.

10 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesPurified Water, Glycolic Acid, SD Alcohol 40B(13% v/v), Hamamelis Virginiana (Witch Hazel) Water, Ammonium Hydroxide, Polysorbate-20, Sodium Benzoate, Imidazolidinyl Urea, Acetone, Disodium EDTA.

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerTopiderm, Inc.
FDA applicationM006 (OTC MONOGRAPH DRUG)
Labeler code51326
First marketedMay 2019
Product typeHuman Otc Drug
Portfolio47 products on file

More NDCs from Topiderm, Inc. labeler code 51326

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Keep Out of Reach of Children 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 16 words ▾

Uses Cleansing pads for the treatment of acne, with the skin enhancement properties of Glycolic acid.

⏱️ Dosage and Administration 61 words ▾

Directions Wipe the entire affected area with a moist pad one to three times daily. Because excessive drying of the skin can occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a physician. If bothersome dryness or peeling occurs, reduce application to once a day or every other day.

⚠️ Warnings 110 words ▾

Warnings For external use only. Keep away from eyes, lips, and mouth. If irritation develops, discontinue use and consult a doctor.

Using other topical acne medication at the same time or immediately following use of this product may increase dryness or irritation of the skin. If this occurs, only one medication should be used unless directed by a doctor. Keep out of reach of children.

If swallowed, seek professional assistance or contact a Poison Control Center immediately. Flammable; keep tightly closed, away from flame and heat. Sunscreen use is recommended with any Glycolic Acid product and for an additional week thereafter, because some individuals may be more sensitive to sunlight.

🧪 Active Ingredient 6 words ▾

Active ingredient Salicylic Acid USP, 2%

🧪 Inactive Ingredients 25 words ▾

Inactive ingredients Purified Water, Glycolic Acid, SD Alcohol 40B(13% v/v), Hamamelis Virginiana (Witch Hazel) Water, Ammonium Hydroxide, Polysorbate-20, Sodium Benzoate, Imidazolidinyl Urea, Acetone, Disodium EDTA.

🎯 Purpose 3 words ▾

Purpose Acne medication

📄 Keep Out of Reach of Children 51 words ▾

Keep out of reach of children. If swallowed, seek professional assistance or contact a Poison Control Center immediately. Flammable; keep tightly closed, away from flame and heat. Sunscreen use is recommended with any Glycolic Acid product and for an additional week thereafter, because some individuals may be more sensitive to sunlight.

📄 Package Label / Principal Display Panel 38 words ▾

PRINCIPAL DISPLAY PANEL - 60 Pad Jar COMPLIMENTS OF TOPIX PHARMACEUTICALS, INC Gly / Sal 10-2 Pads Glycolic Acid 10% Salicylic Acid USP, 2% 60 pads Available Custom Branded 800.445.2595 [email protected] Principal Display Panel - 60 Pad Jar

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Salicylic Acid (matched by generic name) — the program that covers self-administered drugs. 2 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Salicylic Acid. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$11.2K
Claims incl. refills
43
Beneficiaries
35
Spend / beneficiary
$319.01
Spend / claim
$259.66
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Topiderm, Inc.. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
Topiderm, Inc. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 51326-0615-23 · Topiderm, 51326-0801-01 · Topiderm, →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.